Latest News

Amdocs Limited Files Fiscal 2017 Annual Report

ST. LOUIS, Dec. 11, 2017 -- Amdocs Limited (NASDAQ:DOX) has filed its Annual Report on Form 20-F for the fiscal year ended September 30, 2017 (including its financial statements for such year) with the U.S. Securities and Exchange Commission. The annual report is available through the Company’s website (http://www.amdocs.com/media-room/annual-report-2017). Upon the request of a shareholder of the Company, the Company will promptly provide to such shareholder a copy of the 2017 annual report, free...

Published on .

The New Ireland Fund Announces Final Results of Rights Offering

BOSTON, Dec. 11, 2017 -- The Board of Directors (the “Board”) of The New Ireland Fund (NYSE:IRL) (the “Fund”), a closed-end investment company, is pleased to announce the completion of the Fund’s transferable rights offering (the “Offer”) in which 1,245,445 common shares will be issued pursuant to subscriptions by rights holders through the Offer.   The Offer, which commenced on November 3, 2017 and expired on December 6, 2017 (the “Expiration Date”), was oversubscribed. ...

Published on .

Archrock Names Raymond Guba Interim Chief Financial Officer

HOUSTON, Dec. 11, 2017 -- Archrock, Inc. (NYSE:AROC) today announced that Raymond (Randy) Guba has been appointed Interim Chief Financial Officer, effective December 12, 2017.“Archrock is fortunate to have an Interim CFO with Randy’s broad financial experience and proven leadership to support our team,” said Brad Childers, Archrock’s President and Chief Executive Officer. “I look forward to working with him as we continue our search for a permanent CFO.”Guba brings extensive financial...

Published on .

Archrock Partners Names Raymond Guba Interim Chief Financial Officer

HOUSTON, Dec. 11, 2017 -- HOUSTON, December 11, 2017 – Archrock Partners, L.P. (NASDAQ:APLP) today announced that Raymond (Randy) Guba has been appointed Interim Chief Financial Officer of Archrock Partners’ managing general partner, effective December 12, 2017.“Archrock Partners is fortunate to have an Interim CFO with Randy’s broad financial experience and proven leadership to support our team,” said Brad Childers, Chairman, President and Chief Executive Officer of Archrock Partners’...

Published on .

TriCo Bancshares Enters San Francisco Bay Area With Acquisition of FNB Bancorp

CHICO, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--TriCo Bancshares (“TriCo”) (NASDAQ:TCBK) and FNB Bancorp (“FNB”) (NASDAQ:FNBG) today announced that they have entered into a definitive agreement under which TriCo, parent company of Tri Counties Bank, will acquire FNB, parent company of First National Bank of Northern California (“FNB NorCal”), in a stock transaction valued at approximately $315.3 million in aggregate, or $40.81 per share based on the closing price of...

Published on .

Commissioning Event Celebrates Operation of 179 Megawatt Switch Station 1 and Switch Station 2 Solar Projects in Apex, Nevada

APEX, Nev.--(BUSINESS WIRE)--Switch Station 1 and Switch Station 2 solar power plants, with a combined generation capacity of 179 MWac, were formally recognized today as fully commissioned and in commercial operation at a celebration attended by government officials, project owners and the energy offtaker. U.S. Senator Harry Reid, U.S Bureau of Land Management Nevada Director, John Ruhs, Clark County Commissioner Chairman Steve Sisolak, Nevada State Energy Office Director Angela Dykema and other...

Published on .

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Inventure Foods, Inc.

NEW YORK, Dec. 11, 2017 -- Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the District of Arizona, case no. 2:17-cv-04256, on behalf of shareholders of Inventure Foods, Inc. ("Inventure Foods" or the "Company") (NASDAQ: SNAK) who held Inventure Foods common stock and have been harmed by Inventure Foods' and its board of directors' (the "Board") alleged violations of Sections 14(e), 14(d)(4), and 20(a)...

Published on .

Rogers Communications 4Q17 Investment Community Teleconference January 25, 2018 at 8:00 a.m. ET

TORONTO, Dec. 11, 2017 - Rogers Communications Inc. plans to release its fourth quarter 2017 financial results on Thursday, January 25, 2018 before North American financial markets open. The results will be distributed by newswire and posted at investors.rogers.com. Rogers' management will host its quarterly teleconference with the investment community to discuss the results and outlook at 8:00 a.m. ET.  Those wishing to listen to the teleconference should access the live webcast...

Published on .

IRET Announces Fiscal Second Quarter 2018 Results

MINOT, N.D., Dec. 11, 2017 -- IRET (NYSE: IRET) announced today its fiscal second quarter 2018 financial and operating results.  Net income and Funds from Operations ("FFO") per share for the three and six months ended October 31, 2017, are detailed below.  Core FFO adjusts FFO for certain non-routine items, and both FFO and Core FFO are reconciled to net income in the tables accompanying this earnings release. Three months Ended Six Months Ended  October...

Published on .

Pershing Gold Announces Bought Deal of $6.8 Million

LAKEWOOD, CO, Dec. 11, 2017 - Pershing Gold Corporation (NASDAQ: PGLC), (TSX:PGLC), (FWB:7PG1) ("Pershing Gold" or the "Company"), an emerging Nevada gold producer, today announced that it has entered into an underwriting agreement with a syndicate of underwriters (the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal underwritten basis, 2,430,000 shares of its common stock and warrants to purchase up to 972,000 shares of its common stock, at a price...

Published on .

Eaton Vance National Municipal Opportunities Trust Declares Capital Gain Distributions

BOSTON, Dec. 11, 2017 -- Eaton Vance announced a distribution today on one of its closed-end funds (the "Fund") as detailed below. Declaration – 12/11/2017    Ex-Date – 12/20/2017    Record – 12/21/2017    Payable – 12/27/17 Fund Ticker Short-Term Capital Gain Distribution Per Share Long-Term Capital Gain Distribution Per Share Eaton Vance National Municipal Opportunities Trust EOT $0.0012 $0.1206 The Fund's distributions...

Published on .

SIGMA DESIGNS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigma Designs, Inc.

NEW ORLEANS, Dec. 11, 2017 -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Sigma Designs, Inc. ("Sigma" or the "Company") (Nasdaq: SIGM) to Silicon Laboratories Inc. (Nasdaq: SLAB).  Under the terms of the proposed transaction, shareholders of Sigma will receive only $7.05 for each share of Sigma that they own. KSF is seeking to determine whether this consideration and the...

Published on .

Datacenter Industry Senior Executive Kimberly Sheehy Joins Switch Board of Directors

LAS VEGAS, Dec. 11, 2017 -- Switch, Inc. (NYSE: SWCH) ("Switch") today announced that Kimberly Sheehy has been appointed to Switch's Board of Directors.  As the former CFO of CyrusOne, Mrs. Sheehy has vast experience in the multitenant datacenter market.  Kimberly Sheehy Prior to joining Switch's Board of Directors, Ms. Sheehy served as Chief Financial Officer of StackPath, LLC from December 2015 through October 2017. Prior to joining StackPath, Ms. Sheehy served...

Published on .

Fate Therapeutics Announces Day 100 Clinical Results from Phase 1 Stage of PROTECT Trial of ProTmune™ and Initiation of Phase 2 Stage

All Subjects Achieved Day 100 Relapse-free SurvivalAll Incidents of Day 100 Acute GvHD Responded to Steroid TreatmentRandomized, Controlled and Double-Blinded Phase 2 Stage of PROTECT Now EnrollingSAN DIEGO, Dec. 11, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today Day 100 clinical data from the Phase 1 stage of its PROTECT clinical trial of...

Published on .

Editas Medicine Reports Data Supporting Multiple Approaches to Create Treatments for Sickle Cell Disease and Beta-Thalassemia

CAMBRIDGE, Mass., Dec. 11, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from experiments to demonstrate expanded CRISPR genome editing strategies in hematopoietic stem cells for the treatment of hematologic diseases such as sickle cell disease and beta-thalassemia. In these proof of concept experiments, the Company demonstrated CRISPR/Cas9 homology directed repair (HDR) and CRISPR/Cpf1-directed editing in human CD34+ cells. The Company reported...

Published on .